Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 273591, 10 pages
http://dx.doi.org/10.1155/2012/273591
Review Article

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders

1Department of Internal Medicine, Mercy Fitzgerald Hospital, Darby, PA 19018, USA
2Sleep Medicine Services, Bryn Mawr Hospital, PA 19010, USA

Received 27 February 2012; Accepted 4 June 2012

Academic Editor: Gulfer Okumus

Copyright © 2012 Ayodeji Adegunsoye and Siva Ramachandran. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Roux, C. D'Ambrosio, and V. Mohsenin, “Sleep-related breathing disorders and cardiovascular disease,” American Journal of Medicine, vol. 108, no. 5, pp. 396–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Galiè, M. M. Hoeper, M. Humbert et al., “Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT),” European Heart Journal, vol. 30, no. 20, pp. 2493–2537, 2009. View at Google Scholar
  3. J. Houtchens, D. Martin, and J. R. Klinger, “Diagnosis and management of pulmonary arterial hypertension,” Pulmonary Medicine, vol. 2011, Article ID 845864, 13 pages, 2011. View at Publisher · View at Google Scholar
  4. T. L. Kiefer and T. M. Bashore, “Pulmonary hypertension related to left-sided cardiac pathology,” Pulmonary Medicine, vol. 2011, Article ID 381787, 11 pages, 2011. View at Publisher · View at Google Scholar
  5. A. L. Rafanan, J. A. Golish, D. S. Dinner, L. K. Hague, and A. C. Arroliga, “Nocturnal hypoxemia is common in primary pulmonary hypertension,” Chest, vol. 120, no. 3, pp. 894–899, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Alchanatis, G. Tourkohoriti, S. Kakouros, E. Kosmas, S. Podaras, and J. B. Jordanoglou, “Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics,” Respiration, vol. 68, no. 6, pp. 566–572, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Apprill, E. Weitzenblum, J. Krieger, M. Oswald, and D. Kurtz, “Frequency and mechanism of daytime pulmonary hypertension in patients with obstructive sleep apnoea syndrome,” Cor et Vasa, vol. 33, no. 1, pp. 42–49, 1991. View at Google Scholar · View at Scopus
  8. E. Bady, A. Achkar, S. Pascal, E. Orvoen-Frija, and J. P. Laaban, “Pulmonary arterial hypertension in patients with sleep apnoea syndrome,” Thorax, vol. 55, no. 11, pp. 934–939, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Chaouat, E. Weitzenblum, J. Krieger, M. Oswald, and R. Kessler, “Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients,” Chest, vol. 109, no. 2, pp. 380–386, 1996. View at Google Scholar · View at Scopus
  10. J. Krieger, E. Sforza, M. Apprill, E. Lampert, E. Weitzenblum, and J. Ratomaharo, “Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients,” Chest, vol. 96, no. 4, pp. 729–737, 1989. View at Google Scholar · View at Scopus
  11. L. Laks, B. Lehrhaft, R. R. Grunstein, and C. E. Sullivan, “Pulmonary hypertension in obstructive sleep apnoea,” European Respiratory Journal, vol. 8, no. 4, pp. 537–541, 1995. View at Google Scholar · View at Scopus
  12. M. Niijima, H. Kimura, H. Edo et al., “Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 6, pp. 1766–1772, 1999. View at Google Scholar · View at Scopus
  13. T. Podszus, W. Bauer, and J. Mayer, “Sleep apnea and pulmonary hypertension,” Klinische Wochenschrift, vol. 64, no. 3, pp. 131–134, 1986. View at Google Scholar · View at Scopus
  14. D. Sajkov, T. Wang, N. A. Saunders, A. J. Bune, A. M. Neill, and R. D. McEvoy, “Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5, pp. 1518–1526, 1999. View at Google Scholar · View at Scopus
  15. B. M. Sanner, C. Doberauer, M. Konermann, A. Sturm, and W. Zidek, “Pulmonary hypertension in patients with obstructive sleep apnea syndrome,” Archives of Internal Medicine, vol. 157, no. 21, pp. 2483–2487, 1997. View at Google Scholar · View at Scopus
  16. E. Weitzenblum, J. Krieger, M. Apprill et al., “Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome,” American Review of Respiratory Disease, vol. 138, no. 2, pp. 345–349, 1988. View at Google Scholar · View at Scopus
  17. H. Yamakawa, T. Shiomi, R. Sasanabe et al., “Pulmonary hypertension in patients with severe obstructive sleep apnea,” Psychiatry and Clinical Neurosciences, vol. 56, no. 3, pp. 311–312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. W. Atwood, D. McCrory, J. G. N. Garcia, S. H. Abman, and G. S. Ahearn, “Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines,” Chest, vol. 126, no. 1, pp. 72S–77S, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Grigg-Damberger, “Why a polysomnogram should become part of the diagnostic evaluation of stroke and transient ischemic attack,” Journal of Clinical Neurophysiology, vol. 23, no. 1, pp. 21–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Kasasbeh, D. S. Chi, and G. Krishnaswamy, “Inflammatory aspects of sleep apnea and their cardiovascular consequences,” Southern Medical Journal, vol. 99, no. 1, pp. 58–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Golbin, V. K. Somers, and S. M. Caples, “Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension,” Proceedings of the American Thoracic Society, vol. 5, no. 2, pp. 200–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler et al., “Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 3, pp. 1151–1158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. B. M. Sanner, M. Konermann, M. Tepel, J. Groetz, C. Mummenhoff, and W. Zidek, “Platelet function in patients with obstructive sleep apnoea syndrome,” European Respiratory Journal, vol. 16, no. 4, pp. 648–652, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Tuder, S. H. Abman, T. Braun et al., “Development and pathology of pulmonary hypertension,” Journal of the American College of Cardiology, vol. 54, no. 1, supplement 1, pp. S3–S9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. E. D'Alonzo, R. J. Barst, S. M. Ayres et al., “Survival in patients with primary pulmonary hypertension: results from a national prospective registry,” Annals of Internal Medicine, vol. 115, no. 5, pp. 343–349, 1991. View at Google Scholar · View at Scopus
  26. V. K. Somers, M. E. Dyken, A. L. Mark, and F. M. Abboud, “Sympathetic-nerve activity during sleep in normal subjects,” The New England Journal of Medicine, vol. 328, no. 5, pp. 303–307, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers, “Obstructive sleep apnea: implications for cardiac and vascular disease,” JAMA, vol. 290, no. 14, pp. 1906–1914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. B. G. Judd, S. Liu, and M. J. Sateia, “Cardiovascular abnormalities in sleep-disordered breathing,” Seminars in Respiratory and Critical Care Medicine, vol. 24, no. 3, pp. 315–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. Hudgel, “Mechanisms of obstructive sleep apnea,” Chest, vol. 101, no. 2, pp. 541–549, 1992. View at Google Scholar · View at Scopus
  30. W. W. Flemons, D. Buysse, S. Redline et al., “Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research,” Sleep, vol. 22, no. 5, pp. 667–689, 1999. View at Google Scholar · View at Scopus
  31. J. R. Stradling, C. Barbour, J. Glennon, B. A. Langford, and J. H. Crosby, “Which aspects of breathing during sleep influence the overnight fall of blood pressure in a community population?” Thorax, vol. 55, no. 5, pp. 393–398, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. V. K. Somers, D. P. White, R. Amin et al., “Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health),” Journal of the American College of Cardiology, vol. 52, no. 8, pp. 686–717, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Harris, N. Glozier, R. Ratnavadivel, and R. R. Grunstein, “Obstructive sleep apnea and depression,” Sleep Medicine Reviews, vol. 13, no. 6, pp. 437–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J.-D. L. Lattimore, D. S. Celermajer, and I. Wilcox, “Obstructive sleep apnea and cardiovascular disease,” Journal of the American College of Cardiology, vol. 41, no. 9, pp. 1429–1437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. P. M. Simon, S. Landry, and J. C. Leiter, “Respiratory control during sleep,” in Sleep Medicine, T. L. Lee-Chiong Jr., M. Sateia, and M. Carskadon, Eds., pp. 41–51, Hanley and Belfus, Philadelphia, Pa, USA, 2002. View at Google Scholar
  36. J. W. Weiss, S. Remsburg, E. Garpestad, J. Ringler, D. Sparrow, and J. A. Parker, “Hemodynamic consequences of obstructive sleep apnea,” Sleep, vol. 19, no. 5, pp. 388–397, 1996. View at Google Scholar · View at Scopus
  37. S. Chokroverty, “Physiologic changes in sleep,” in Sleep Disorders Medicine, S. Chokroverty, Ed., pp. 95–126, Butterworth-Heinemann, Woburn, Mass, USA, 1999. View at Google Scholar
  38. P. E. Peppard, T. Young, M. Palta, and J. Skatrud, “Prospective study of the association between sleep-disordered breathing and hypertension,” The New England Journal of Medicine, vol. 342, no. 19, pp. 1378–1384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Shahar, C. W. Whitney, S. Redline et al., “Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 1, pp. 19–25, 2001. View at Google Scholar · View at Scopus
  40. R. S. T. Leung and T. Douglas Bradley, “Sleep apnea and cardiovascular disease,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 12, pp. 2147–2165, 2002. View at Google Scholar · View at Scopus
  41. C. Fava, M. Montagnana, E. J. Favaloro, G. C. Guidi, and G. Lippi, “Obstructive sleep apnea syndrome and cardiovascular diseases,” Seminars in Thrombosis and Hemostasis, vol. 37, no. 3, pp. 280–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Caples, A. Garcia-Touchard, and V. K. Somers, “Sleep-disordered breathing and cardiovascular risk,” Sleep, vol. 30, no. 3, pp. 291–304, 2007. View at Google Scholar · View at Scopus
  43. A. Chaouat, E. Weitzenblum, J. Krieger, M. Oswald, and R. Kessler, “Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients,” Chest, vol. 109, no. 2, pp. 380–386, 1996. View at Google Scholar · View at Scopus
  44. E. C. Fletcher, J. W. Schaaf, J. Miller, and J. G. Fletcher, “Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease,” American Review of Respiratory Disease, vol. 135, no. 3, pp. 525–533, 1987. View at Google Scholar · View at Scopus
  45. T. Shiomi, C. Guilleminault, R. Stoohs, and I. Schnittger, “Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome,” Chest, vol. 100, no. 4, pp. 894–902, 1991. View at Google Scholar · View at Scopus
  46. R. Stoohs and C. Guilleminault, “Cardiovascular changes associated with obstructive sleep apnea syndrome,” Journal of Applied Physiology, vol. 72, no. 2, pp. 583–589, 1992. View at Google Scholar · View at Scopus
  47. J. Virolainen, M. Ventila, H. Turto, and M. Kupari, “Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation,” Journal of Applied Physiology, vol. 79, no. 2, pp. 455–460, 1995. View at Google Scholar · View at Scopus
  48. S. G. White, E. C. Fletcher, and C. C. Miller, “Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates,” Journal of Applied Physiology, vol. 79, no. 1, pp. 324–330, 1995. View at Google Scholar · View at Scopus
  49. T. D. Bradley, “Right and left ventricular functional impairment and sleep apnea,” Clinics in Chest Medicine, vol. 13, no. 3, pp. 459–479, 1992. View at Google Scholar · View at Scopus
  50. B. J. Morgan, T. Denahan, and T. J. Ebert, “Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea,” Journal of Applied Physiology, vol. 74, no. 6, pp. 2969–2975, 1993. View at Google Scholar · View at Scopus
  51. V. K. Somers, M. E. Dyken, and J. L. Skinner, “Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans,” Journal of the Autonomic Nervous System, vol. 44, no. 2-3, pp. 253–259, 1993. View at Google Scholar · View at Scopus
  52. A. G. Tilkian, C. Guilleminault, and J. S. Schroeder, “Hemodynamics in sleep induced apnea. Studies during wakefulness and sleep,” Annals of Internal Medicine, vol. 85, no. 6, pp. 714–719, 1976. View at Google Scholar · View at Scopus
  53. J. Motta, C. Guilleminault, J. S. Schroeder, and W. C. Dement, “Tracheostomy and hemodynamic changes in sleep-induced apnea,” Annals of Internal Medicine, vol. 89, no. 4, pp. 454–458, 1978. View at Google Scholar · View at Scopus
  54. C. Guilleminault, J. Motta, F. Mihm, and K. Melvin, “Obstructive sleep apnea and cardiac index,” Chest, vol. 89, no. 3, pp. 331–334, 1986. View at Google Scholar · View at Scopus
  55. W. T. McNicholas and M. R. Bonsignore, “Sleep apnoea as an independent risk for cardiovascular disease: current evidence, basic mechanisms and research priorities,” European Respiratory Journal, vol. 29, no. 1, pp. 156–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. J. S. Schroeder, J. Motta, and C. Guilleminault, “Hemodynamic studies in sleep apnea,” in Sleep Apnea Syndromes, C. Guilleminault and W. C. Dement, Eds., pp. 177–196, Alan R. Liss, New York, NY, USA, 1978. View at Google Scholar
  57. M. G. Ziegler, R. Nelesen, P. Mills, S. Ancoli-Israel, B. Kennedy, and J. E. Dimsdale, “Sleep apnea, norepinephrine-release rate, and daytime hypertension,” Sleep, vol. 20, no. 3, pp. 224–231, 1997. View at Google Scholar · View at Scopus
  58. V. K. Somers, A. L. Mark, D. C. Zavala, and F. M. Abboud, “Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans,” Journal of Applied Physiology, vol. 67, no. 5, pp. 2101–2106, 1989. View at Google Scholar · View at Scopus
  59. M. L. Smith, O. N. W. Niedermaier, S. M. Hardy, M. J. Decker, and K. P. Strohl, “Role of hypoxemia in sleep apnea-induced sympathoexcitation,” Journal of the Autonomic Nervous System, vol. 56, no. 3, pp. 184–190, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Otsuka, M. Ohi, K. Chin et al., “Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome,” Journal of Nuclear Medicine, vol. 38, no. 4, pp. 567–572, 1997. View at Google Scholar · View at Scopus
  61. C. Zwillich, T. Devlin, and D. White, “Bradycardia during sleep apnea. Characteristics and mechanism,” The Journal of Clinical Investigation, vol. 69, no. 6, pp. 1286–1292, 1982. View at Google Scholar · View at Scopus
  62. T. Imaizumi, “Arrhythmias in sleep apnea,” American Heart Journal, vol. 100, no. 4, pp. 513–516, 1980. View at Google Scholar · View at Scopus
  63. C. Guilleminault, S. J. Connolly, and R. A. Winkle, “Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome,” American Journal of Cardiology, vol. 52, no. 5, pp. 490–494, 1983. View at Google Scholar · View at Scopus
  64. J. W. Shepard, M. W. Garrison, D. A. Grither, and G. F. Dolan, “Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea,” Chest, vol. 88, no. 3, pp. 335–340, 1985. View at Google Scholar · View at Scopus
  65. J. W. Shepard, “Cardiopulmonary consequences of obstructive sleep apnea,” Mayo Clinic Proceedings, vol. 65, no. 9, pp. 1250–1259, 1990. View at Google Scholar · View at Scopus
  66. K. D. O'Halloran and A. Bradford, “The pathophysiology of sleep apnoea: what we have learned from animal models of chronic intermittent hypoxia,” Current Respiratory Medicine Reviews, vol. 3, no. 1, pp. 19–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Sajkov, R. J. Cowie, A. T. Thornton, H. A. Espinoza, and R. D. McEvoy, “Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 2, pp. 416–422, 1994. View at Google Scholar · View at Scopus
  68. L. Laks, B. Lehrhaft, R. R. Grunstein, and C. E. Sullivan, “Pulmonary artery pressure response to hypoxia in sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 193–198, 1997. View at Google Scholar · View at Scopus
  69. A. Chaouat, E. Weitzenblum, J. Krieger, M. Oswald, and R. Kessler, “Pulmonary hemodynamics in obstructive sleep apnea syndrome. Results in 220 consecutive patients,” Chest, vol. 109, no. 2, pp. 380–386, 1996. View at Google Scholar · View at Scopus
  70. K. Ramar and C. Guilleminault, “Cardiovascular complications of obstructive sleep apnea,” Expert Review of Respiratory Medicine, vol. 2, no. 1, pp. 63–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. E. J. Berman, R. J. DiBenedetto, D. E. Causey et al., “Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea,” Chest, vol. 100, no. 2, pp. 347–350, 1991. View at Google Scholar · View at Scopus
  72. A. Noda, T. Okada, F. Yasuma, N. Nakashima, and M. Yokota, “Cardiac hypertrophy in obstructive sleep apnea syndrome,” Chest, vol. 107, no. 6, pp. 1538–1544, 1995. View at Google Scholar · View at Scopus
  73. A. Foucher, “Cardiovascular consequences ofsleep apnea,” Nephrologie et Therapeutique, vol. 3, no. 7, pp. 463–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. Q. Ahmed, M. Chung-Park, and J. F. Tomashefski, “Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome,” Human Pathology, vol. 28, no. 3, pp. 264–269, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Lavie and P. Lavie, “Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link,” European Respiratory Journal, vol. 33, no. 6, pp. 1467–1484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. R. T. Dean, I. Wilcox, C. Sullivan et al., “Possible atherogenic effects of hypoxia during obstructive sleep apnea,” Sleep, vol. 16, no. 8, pp. S15–S22, 1993. View at Google Scholar · View at Scopus
  77. B. Halliwell, “The role of oxygen radicals in human disease, with particular reference to the vascular system,” Haemostasis, vol. 23, no. 1, pp. 118–126, 1993. View at Google Scholar · View at Scopus
  78. R. Schulz, S. Mahmoudi, K. Hattar et al., “Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, pp. 566–570, 2000. View at Google Scholar · View at Scopus
  79. N. R. Prabhakar, “Sleep apneas: an oxidative stress?” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 859–860, 2002. View at Google Scholar · View at Scopus
  80. J. A. Dempsey, S. C. Veasey, B. J. Morgan, and C. P. O'Donnell, “Pathophysiology of sleep apnea,” Physiological Reviews, vol. 90, no. 1, pp. 47–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Narkiewicz, P. J. H. Van De Borne, R. L. Cooley, M. E. Dyken, and V. K. Somers, “Sympathetic activity in obese subjects with and without obstructive sleep apnea,” Circulation, vol. 98, no. 8, pp. 772–776, 1998. View at Google Scholar · View at Scopus
  82. K. Narkiewicz, P. J. H. Van De Borne, N. Montano, M. E. Dyken, B. G. Phillips, and V. K. Somers, “Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea,” Circulation, vol. 97, no. 10, pp. 943–945, 1998. View at Google Scholar · View at Scopus
  83. J. M. Parish and V. K. Somers, “Obstructive sleep apnea and cardiovascular disease,” Mayo Clinic Proceedings, vol. 79, no. 8, pp. 1036–1046, 2004. View at Google Scholar · View at Scopus
  84. K. Narkiewicz, N. Montano, C. Cogliati, P. J. H. Van De Borne, M. E. Dyken, and V. K. Somers, “Altered cardiovascular variability in obstructive sleep apnea,” Circulation, vol. 98, no. 11, pp. 1071–1077, 1998. View at Google Scholar · View at Scopus
  85. J. P. Singh, M. G. Larson, H. Tsuji, J. C. Evans, C. J. O'Donnell, and D. Levy, “Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study,” Hypertension, vol. 32, no. 2, pp. 293–297, 1998. View at Google Scholar · View at Scopus
  86. P. Ponikowski, S. D. Anker, T. P. Chua et al., “Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 79, no. 12, pp. 1645–1650, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. J. P. Baguet, G. Barone-Rochette, and J. L. Pépin, “Hypertension and obstructive sleep apnoea syndrome: current perspectives,” Journal of Human Hypertension, vol. 23, no. 7, pp. 431–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. B. G. Phillips, K. Narkiewicz, C. A. Pesek, W. G. Haynes, M. E. Dyken, and V. K. Somers, “Effects of obstructive sleep apnea on endothelin-1 and blood pressure,” Journal of Hypertension, vol. 17, no. 1, pp. 61–66, 1999. View at Google Scholar · View at Scopus
  89. R. Schulz, D. Schmidt, A. Blum et al., “Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy,” Thorax, vol. 55, no. 12, pp. 1046–1051, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Kato, P. Roberts-Thomson, B. G. Phillips et al., “Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea,” Circulation, vol. 102, no. 21, pp. 2607–2610, 2000. View at Google Scholar · View at Scopus
  91. R. Wolk and V. K. Somers, “Obesity-related cardiovascular disease: implications of obstructive sleep apnea,” Diabetes, Obesity and Metabolism, vol. 8, no. 3, pp. 250–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Zamarrón, F. D. C. Matias, and C. J. Egea, “Obstructive sleep apnea syndrome: implications in cardiovascular disease,” Current Respiratory Medicine Reviews, vol. 5, no. 4, pp. 242–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” The New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Davì, M. T. Guagnano, G. Ciabattoni et al., “Platelet activation in obese women: role of inflammation and oxidant stress,” JAMA, vol. 288, no. 16, pp. 2008–2014, 2002. View at Google Scholar · View at Scopus
  95. A. M. Wallace, A. D. McMahon, C. J. Packard et al., “Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS),” Circulation, vol. 104, no. 25, pp. 3052–3056, 2001. View at Google Scholar · View at Scopus
  96. B. G. Phillips, M. Kato, K. Narkiewicz, I. Choe, and V. K. Somers, “Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea,” American Journal of Physiology, vol. 279, no. 1, pp. H234–H237, 2000. View at Google Scholar · View at Scopus
  97. K. Chin, K. Shimizu, T. Nakamura et al., “Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy,” Circulation, vol. 100, no. 7, pp. 706–712, 1999. View at Google Scholar · View at Scopus
  98. N. A. Collop, “Obstructive sleep apnea: what does the cardiovascular physician need to know?” American Journal of Cardiovascular Drugs, vol. 5, no. 2, pp. 71–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Elmasry, E. Lindberg, C. Berne et al., “Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study,” Journal of Internal Medicine, vol. 249, no. 2, pp. 153–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. M. S. M. Ip, B. Lam, M. M. T. Ng, W. K. Lam, K. W. T. Tsang, and K. S. L. Lam, “Obstructive sleep apnea is independently associated with insulin resistance,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 670–676, 2002. View at Google Scholar · View at Scopus
  101. N. M. Punjabi, J. D. Sorkin, L. I. Katzel, A. P. Goldberg, A. R. Schwartz, and P. L. Smith, “Sleep-disordered breathing and insulin resistance in middle-aged and overweight men,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 677–682, 2002. View at Google Scholar · View at Scopus
  102. F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers, “Obstructive sleep apnea: implications for cardiac and vascular disease,” Chest, vol. 133, no. 3, pp. 793–804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. H. E. Dincer, “Clinical utility of biochemical markers of obstructive sleep apnea,” Clinical Pulmonary Medicine, vol. 14, no. 1, pp. 38–44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. J. M. Parish and V. K. Somers, “Obstructive sleep apnea and cardiovascular disease,” Mayo Clinic Proceedings, vol. 79, no. 8, pp. 1036–1046, 2004. View at Google Scholar · View at Scopus
  105. E. Kasasbeh, D. S. Chi, and G. Krishnaswamy, “Inflammatory aspects of sleep apnea and their cardiovascular consequences,” Southern Medical Journal, vol. 99, no. 1, pp. 58–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. G. Hartmann, M. Tschöp, R. Fischer et al., “High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein,” Cytokine, vol. 12, no. 3, pp. 246–252, 2000. View at Publisher · View at Google Scholar · View at Scopus
  107. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler et al., “Circadian interleukin-6 secretion and quantity and depth of sleep,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 8, pp. 2603–2607, 1999. View at Google Scholar · View at Scopus
  108. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, A. Kales, K. Tyson, and G. P. Chrousos, “Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1313–1316, 1997. View at Google Scholar · View at Scopus
  109. A. S. M. Shamsuzzaman, M. Winnicki, P. Lanfranchi et al., “Elevated C-reactive protein in patients with obstructive sleep apnea,” Circulation, vol. 105, no. 21, pp. 2462–2464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. S. K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal, “Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells,” Circulation, vol. 106, no. 12, pp. 1439–1441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. K. J. Woollard, D. C. Phillips, and H. R. Griffiths, “Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells,” Clinical and Experimental Immunology, vol. 130, no. 2, pp. 256–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  112. I. Eisensehr, B. L. Ehrenberg, S. Noachtar et al., “Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome,” Neurology, vol. 51, no. 1, pp. 188–195, 1998. View at Google Scholar · View at Scopus
  113. G. Bokinsky, M. Miller, K. Ault, P. Husband, and J. Mitchell, “Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation,” Chest, vol. 108, no. 3, pp. 625–630, 1995. View at Google Scholar · View at Scopus
  114. V. Hoffstein, M. Herridge, S. Mateika, S. Redline, and K. P. Strohl, “Hematocrit levels in sleep apnea,” Chest, vol. 106, no. 3, pp. 787–791, 1994. View at Google Scholar · View at Scopus
  115. K. Chin, M. Ohi, H. Kita et al., “Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 6, pp. 1972–1976, 1996. View at Google Scholar · View at Scopus
  116. T. E. Wessendorf, A. F. Thilmann, Y. M. Wang, A. Schreiber, N. Konietzko, and H. Teschler, “Fibrinogen levels and obstructive sleep apnea in ischemic stroke,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2039–2042, 2000. View at Google Scholar · View at Scopus
  117. L. Nobili, G. Schiavi, E. Bozano, F. De Carli, F. Ferrillo, and F. Nobili, “Morning increase of whole blood viscosity in obstructive sleep apnea syndrome,” Clinical Hemorheology and Microcirculation, vol. 22, no. 1, pp. 21–27, 2000. View at Google Scholar · View at Scopus
  118. K. Chin, H. Kita, T. Noguchi et al., “Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome,” QJM, vol. 91, no. 9, pp. 627–633, 1998. View at Google Scholar · View at Scopus
  119. J. M. Golbin, V. K. Somers, and S. M. Caples, “Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension,” Proceedings of the American Thoracic Society, vol. 5, no. 2, pp. 200–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Chaouat, E. Weitzenblum, J. Krieger, M. Oswald, and R. Kessler, “Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients,” Chest, vol. 109, no. 2, pp. 380–386, 1996. View at Google Scholar · View at Scopus
  121. T. Shinozaki, K. Tatsumi, T. Sakuma et al., “Daytime pulmonary hypertension in the obstructive sleep apnea syndrome,” Japanese Journal of Thoracic Diseases, vol. 33, no. 10, pp. 1073–1079, 1995. View at Google Scholar · View at Scopus
  122. L. J. Rubin and D. B. Badesch, “Evaluation and management of the patient with pulmonary arterial hypertension,” Annals of Internal Medicine, vol. 143, no. 4, pp. 282–292, 2005. View at Google Scholar · View at Scopus
  123. S. Ferreira, J. Winck, P. Bettencourt, and F. Rocha-Goncalves, “Heart failure and sleep apnoea: to sleep perchance to dream,” European Journal of Heart Failure, vol. 8, no. 3, pp. 227–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. B. M. Sanner, M. Konermann, A. Sturm, H. J. Müller, and W. Zidek, “Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome,” European Respiratory Journal, vol. 10, no. 9, pp. 2079–2083, 1997. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Sajkov, T. Wang, N. A. Saunders, A. J. Bune, and R. D. Mcevoy, “Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 2, pp. 152–158, 2002. View at Google Scholar · View at Scopus
  126. V. Jain, “Clinical perspective of obstructive sleep apnea-induced cardiovascular complications,” Antioxidants and Redox Signaling, vol. 9, no. 6, pp. 701–710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. N. A. Collop, “Obstructive sleep apnea syndromes,” Seminars in Respiratory and Critical Care Medicine, vol. 26, no. 1, pp. 13–24, 2005. View at Publisher · View at Google Scholar
  128. P. J. Hanly and A. Pierratos, “Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis,” The New England Journal of Medicine, vol. 344, no. 2, pp. 102–107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Garrigue, P. Bordier, P. Jaïs et al., “Benefit of atrial pacing in sleep apnea syndrome,” The New England Journal of Medicine, vol. 346, no. 6, pp. 404–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. S. E. Kimmel, J. A. Berlin, C. Miles, J. Jaskowiak, J. L. Carson, and B. L. Strom, “The effect of aspirin on C-reactive protein as a marker of risk in unstable angina,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1266–1270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. M. A. Albert, E. Danielson, N. Rifai, and P. M. Ridker, “Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study,” JAMA, vol. 286, no. 1, pp. 64–70, 2001. View at Google Scholar · View at Scopus
  132. J. K. Plenge, T. L. Hernandez, K. M. Weil et al., “Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction,” Circulation, vol. 106, no. 12, pp. 1447–1452, 2002. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Gaine, “Pulmonary hypertension,” JAMA, vol. 284, no. 24, pp. 3160–3168, 2000. View at Google Scholar · View at Scopus
  134. M. R. Shepertycky, M. Al-Barrak, and M. H. Kryger, “Morbidity and mortality in obstructive sleep apnea syndrome: effect of treatment on cardiovascular morbidity,” Sleep and Biological Rhythms, vol. 1, no. 1, pp. 15–28, 2003. View at Publisher · View at Google Scholar